6 U.S. lawmakers have disclosed 22 Bayer AG trades under the STOCK Act — 8 buys and 14 sells between 2015 and 2026. Congress has been net sellers of BAYRY, and their disclosed buys are up 78.8% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of BAYRY, marked to the latest close — per-share (share counts aren't disclosed).
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-05-29 | Michael T. McCaul | SELL | $1K–$15K | $10.55 | $13.84 2026-08-13 | -31.2% exit |
| 2026-05-12 | Michael T. McCaul | SELL | $1K–$15K | $11.21 | $13.84 2026-08-13 | +44.8% rt |
| 2024-06-06 | Michael T. McCaul | BUY | $15K–$50K | $7.74 | $13.84 2026-08-13 | +78.8% |
| 2019-04-15 | Greg Gianforte | SELL | $250K–$500K | $17.40 | $13.84 2026-08-13 | +20.5% exit |
| 2018-12-12 | Josh Gottheimer | SELL | $1K–$15K | $18.20 | $13.84 2026-08-13 | +24.0% exit |
| 2018-10-01 | DIANNE FEINSTEIN | BUY | $15K–$50K | $22.04 | $13.84 2026-08-13 | -37.2% |
| 2018-10-01 | DIANNE FEINSTEIN | BUY | $15K–$50K | $22.04 | $13.84 2026-08-13 | -37.2% |
| 2018-10-01 | DIANNE FEINSTEIN | BUY | $15K–$50K | $22.04 | $13.84 2026-08-13 | -37.2% |
| 2018-09-28 | DIANNE FEINSTEIN | SELL | $1K–$15K | $22.14 | $13.84 2026-08-13 | +37.5% exit |
| 2018-08-17 | Thomas MacArthur | SELL | $15K–$50K | $22.73 | $13.84 2026-08-13 | +39.1% exit |
| 2018-08-16 | Thomas MacArthur | SELL | $15K–$50K | $21.86 | $13.84 2026-08-13 | +36.7% exit |
| 2018-06-11 | DIANNE FEINSTEIN | SELL | $1K–$15K | $30.15 | $13.84 2026-08-13 | +54.1% exit |
| 2018-04-18 | DIANNE FEINSTEIN | SELL | $1K–$15K | $31.08 | $13.84 2026-08-13 | +55.5% exit |
| 2018-03-22 | DIANNE FEINSTEIN | SELL | $1K–$15K | $28.41 | $13.84 2026-08-13 | +51.3% exit |
| 2018-03-22 | DIANNE FEINSTEIN | SELL | $1K–$15K | $28.41 | $13.84 2026-08-13 | +51.3% exit |
| 2018-03-21 | DIANNE FEINSTEIN | SELL | $1K–$15K | $28.92 | $13.84 2026-08-13 | +52.1% exit |
| 2018-03-21 | DIANNE FEINSTEIN | SELL | $1K–$15K | $28.92 | $13.84 2026-08-13 | +52.1% exit |
| 2017-12-07 | DIANNE FEINSTEIN | SELL | $1K–$15K | $30.78 | $13.84 2026-08-13 | +55.0% exit |
| 2016-05-31 | James B. Renacci | BUY | $1K–$15K | $23.85 | $13.84 2026-08-13 | -42.0% |
| 2016-05-20 | James B. Renacci | BUY | $1K–$15K | $25.05 | $13.84 2026-08-13 | -44.8% |
| 2015-05-19 | James B. Renacci | BUY | $1K–$15K | $38.13 | $13.84 2026-08-13 | -63.7% |
| 2015-02-28 | James B. Renacci | BUY | $1K–$15K | $36.93 | $13.84 2026-08-13 | -62.5% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
6 members of the U.S. House and Senate have disclosed Bayer AG transactions under the STOCK Act — 8 purchases and 14 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a BAYRY purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed BAYRY buys are up 78.8% versus the latest close of $13.84. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded BAYRY and how it performed.